Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease

The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but the...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ji Sook, Seo, Ji Hyun, Youn, Hee-Shang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746040/
https://www.ncbi.nlm.nih.gov/pubmed/24010102
http://dx.doi.org/10.5223/pghn.2013.16.1.22
Descripción
Sumario:The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.

Ejemplares similares